Cargando…
The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19
PURPOSE: To determine the association between low molecular weight heparin (LMWH) use and mortality in hospitalized COVID-19 patients. METHODS: We conducted a retrospective study of patients consecutively enrolled from two major academic hospitals exclusively for COVID-19 in Wuhan, China, from Janua...
Autores principales: | Shen, Lan, Qiu, Lin, Liu, Dong, Wang, Li, Huang, Hengye, Ge, Heng, Xiao, Ying, Liu, Yi, Jin, Jingjin, Liu, Xiulan, Wang, Dao Wen, Peterson, Eric D., He, Ben, Zhou, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779648/ https://www.ncbi.nlm.nih.gov/pubmed/33394360 http://dx.doi.org/10.1007/s10557-020-07133-3 |
Ejemplares similares
-
Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease
por: Shen, Lan, et al.
Publicado: (2021) -
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021) -
Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014) -
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
por: D’Ardes, Damiano, et al.
Publicado: (2020) -
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
por: Mennuni, Marco G., et al.
Publicado: (2021)